BUD — Budget/Appropriations
Support full funding across HHS departments
Lobbyists: ANTHONY THEISSEN; BRIAN ROGERS
Government entities lobbied: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE
1st Quarter - Report · 2026
- Filing UUID
6936ffed-a5f9-42f3-bfc6-3af7af62299e- Type
Q1— 1st Quarter - Report- Period
- first_quarter
- Year
- 2026
- Posted
- 2026-04-17 20:43:10
- Income (reported)
- —
- Expenses (reported)
- $160,000
- Expenses method
- A
- Filing document
- Open on lda.senate.gov
Registrant (lobbying firm)
- Contact
- JAYNE MCNICOL
- Phone
- +1 650-871-3270
- Address
- zip:92121, city:San Diego, state:CA, street:4242 Campus Point Court Suite 110
Client
- State
- CA
- Country
- US
- Government-entity client
- false
- Effective date
- 1996-02-14
Issues lobbied + lobbyists
CPT — Copyright/Patent/Trademark
Support protection of the Bayh-Dole Act and tech transfer process Support transferable exclusivity extensions to incentivize novel antibiotic and rare disease R&D Oppose legislative proposal to reform Patent system and Intellectual Property issues impacting the life sciences ecosystem
Lobbyists: ANTHONY THEISSEN; BRIAN ROGERS
Government entities lobbied: HOUSE OF REPRESENTATIVES; Natl Institute of Standards & Technology (NIST); Natl Institutes of Health (NIH); SENATE
MAN — Manufacturing
Support robust domestic supply chain development and manufacturing ecosystem
Lobbyists: ANTHONY THEISSEN; BRIAN ROGERS
Government entities lobbied: Health & Human Services, Dept of (HHS); SENATE; U.S. Trade Representative (USTR)
SMB — Small Business
Support permanent re-authorization of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs
Lobbyists: ANTHONY THEISSEN; BRIAN ROGERS
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE; Small Business Administration (SBA)
SCI — Science/Technology
Support national strategy and federal privacy framework to bolster infrastructure for artificial intelligence in health care
Lobbyists: ANTHONY THEISSEN; BRIAN ROGERS
Government entities lobbied: HOUSE OF REPRESENTATIVES
TAR — Tariff (miscellaneous tariff bills)
Oppose tariffs that would negatively impact the bio-pharmaceutical and medical device industries
Lobbyists: ANTHONY THEISSEN; BRIAN ROGERS
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
TRD — Trade (domestic/foreign)
Oppose Most Favored Nations Executive Order Submitted comments with regards to the Commerce Department's Section 232 Investigation on Medical Equipment
Lobbyists: ANTHONY THEISSEN; BRIAN ROGERS
Government entities lobbied: Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR)
LBR — Labor Issues/Antitrust/Workplace
Educate policymakers and regulators on the unique role of mergers and acquisitions in the life sciences industry
Lobbyists: ANTHONY THEISSEN; BRIAN ROGERS
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
HCR — Health Issues
Support diversity in clinical trial policy Oppose legislation that expands Medicare Drug Pricing Negotiation Program (MDPNP) Support bipartisan effort to address health care workforce shortage Support incentives for antimicrobial resistance development Support legislation that applies additional payments, discounts, and other financial assistance towards the cost-sharing requirements of health insurance plans Support legislation to prohibit pharmacy benefit managers (PBMs) from linking rebates paid by manufacturers to the list price of a drug and instead implement a flat service fee paid to PBMs Educate Congress on the current state of artificial intelligence in health care and the current regulatory landscape Oppose cap on indirect costs for NIH administered grants Support electronic labeling for all medical devices, regardless of setting of use or the intended user
Lobbyists: ANTHONY THEISSEN; BRIAN ROGERS
Government entities lobbied: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE
MMM — Medicare/Medicaid
Support capping Medicare beneficiary out of pocket costs Oppose legislation to narrow the exclusion for orphan drugs under the MDPNP Support legislation to bring parity to small molecules and biologics with regards to when they qualify for negotiation under the MDPNP Support legislation providing Medicare coverage for anti-obesity medication
Lobbyists: ANTHONY THEISSEN; BRIAN ROGERS
Government entities lobbied: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE
TAX — Taxation/Internal Revenue Code
Support R&D and NOL tax incentives Support full restoration of the Orphan Drug Tax Credit
Lobbyists: ANTHONY THEISSEN; BRIAN ROGERS
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
MED — Medical/Disease Research/Clinical Labs
Support legislation to provide immediate coverage for FDA designated breakthrough medical devices Support legislation proposing coverage for multi-cancer screening Support timely re-authorization of the FDA Pediatric Rare Disease Priority Review Voucher program Support robust funding for the NIH in FY2025 appropriations
Lobbyists: ANTHONY THEISSEN; BRIAN ROGERS
Government entities lobbied: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE